Home › NDC Lookup › RxCUI directory › RxCUI 863758

Oxybutynin chloride 2.5 MG Oral Tablet — RxCUI 863758

Name: Oxybutynin chloride 2.5 MG Oral Tablet (RxCUI 863758)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 863758 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI863758

Official nameOxybutynin chloride 2.5 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped4

Package NDCs mapped8

Reported Medicaid activity (SDUD)39,987 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxybutynin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

The patch works by calming the bladder muscle so it doesn't squeeze unexpectedly. That helps reduce the sudden urge to rush to the bathroom, how often you need to go, and accidenta...
What exactly does this patch do — and how long before I notice a difference?
You can wear the patch on your abdomen, hip, or buttocks — whichever is most comfortable and easiest to keep covered by clothing. Apply it to clean, dry skin with no lotions, oils,...
Where do I put the patch, and how often do I change it?

📖 Read our full Oxybutynin Transdermal Patch guide →

🕸️ Concept Web — How Oxybutynin chloride 2.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Oxybutynin chloride 2.5 MG Oral Tablet RxCUI 863758 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Oxybutynin 32675 IN
- Oxybutynin chloride 54251 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Oxybutynin Oral Tablet 373193 SCDF
- Oxybutynin chloride Oral Tablet 2646088 SCDFP
- Oxybutynin Oral Product 1160155 SCDG
- Oxybutynin Pill 1160156 SCDG
- Oxybutynin chloride Oral Product 2659390 SCDGP
- Oxybutynin chloride Pill 2662465 SCDGP
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Oxybutynin chloride 2.5 MG 863757 SCDC

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Oxybutynin chloride 2.5 MG SCDC · 863757
Oxybutynin Oral Tablet SCDF · 373193
Oxybutynin chloride Oral Tablet SCDFP · 2646088
Oxybutynin Oral Product SCDG · 1160155
Oxybutynin Pill SCDG · 1160156
Oxybutynin chloride Oral Product SCDGP · 2659390
Oxybutynin chloride Pill SCDGP · 2662465

📦 FDA Products & Package NDCs

4 products · 8 package NDCs

8 package NDCs map to RxCUI 863758 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
64380-0162-01	100 TABLET in 1 BOTTLE, PLASTIC (64380-162-01)	Oxybutynin Chloride	Strides Pharma Science Limited	2022-09-30
64380-0162-02	500 TABLET in 1 BOTTLE, PLASTIC (64380-162-02)	Oxybutynin Chloride	Strides Pharma Science Limited	2022-04-04
64380-0162-03	1000 TABLET in 1 BOTTLE, PLASTIC (64380-162-03)	Oxybutynin Chloride	Strides Pharma Science Limited	2022-09-30
64380-0190-01	100 TABLET in 1 BOTTLE (64380-190-01)	Oxybutynin Chloride	Strides Pharma Science Limited	2026-04-10
64980-0431-01	100 TABLET in 1 BOTTLE (64980-431-01)	OXYBUTYNIN CHLORIDE	RISING PHARMA HOLDINGS, INC.	2018-02-01
64980-0431-10	1000 TABLET in 1 BOTTLE (64980-431-10)	OXYBUTYNIN CHLORIDE	RISING PHARMA HOLDINGS, INC.	2018-02-01
64980-0431-50	500 TABLET in 1 BOTTLE (64980-431-50)	OXYBUTYNIN CHLORIDE	RISING PHARMA HOLDINGS, INC.	2018-02-01
64980-0531-01	100 TABLET in 1 BOTTLE (64980-531-01)	OXYBUTYNIN CHLORIDE	RISING PHARMA HOLDINGS, INC.	2023-04-01

Observed labelers: RISING PHARMA HOLDINGS, INC. (4) · Strides Pharma Science Limited (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.